
zzso efficacy in cancer therapy is hampered by the zzso side effects, which may be overcome by reducing the drug's dose and increasing its zzso In the present work, we suggest that the zzso of the nuclear zzso zzso zzso and of zzso zzso zzso increases the zzso efficacy in human colon cancer zzso zzso To induce zzso we took into account the effect of zzso itself and of the zzso zzso A zzso inhibitor zzso as zzso zzso we chose the zzso zzso zzso and zzso zzso increased the zzso activity and NO zzso zzso the zzso zzso of the zzso zzso protein 3, and enhanced the zzso zzso zzso and zzso zzso zzso the effect of zzso on the zzso zzso and the zzso NO zzso zzso The effects of zzso were due to the zzso of the small zzso zzso and of its zzso zzso zzso zzso and zzso prevented all of the zzso effects by inducing zzso zzso zzso On the other hand, they did not reduce the zzso zzso and zzso zzso content when zzso was silenced by small interfering zzso zzso It is interesting that zzso zzso was sufficient to increase zzso zzso NO zzso activity, zzso zzso and zzso also in zzso zzso Our results suggest that zzso a widely used zzso drug, may impair the response to zzso in colon cancer zzso on the contrary, zzso and zzso zzso may represent future therapeutic approaches to improve zzso zzso reducing the risk of zzso adverse zzso 

